Veracyte
VCYT
195 hedge funds and large institutions have $1.37B invested in Veracyte in 2019 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 71 increasing their positions, 50 reducing their positions, and 14 closing their positions.
350% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 14
42% more repeat investments, than reductions
Existing positions increased: 71 | Existing positions reduced: 50
39% more capital invested
Capital invested by funds: $983M → $1.37B (+$385M)
31% more funds holding
Funds holding: 149 → 195 (+46)
4.45% more ownership
Funds ownership: 95.54% → 99.99% (+4.5%)
0% more funds holding in top 10
Funds holding in top 10: 7 → 7 (0)
2% less call options, than puts
Call options by funds: $2.08M | Put options by funds: $2.12M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$59.7M |
| 2 |
NAMA
Nikko Asset Management Americas
New York
|
+$38.4M |
| 3 |
BlackRock
New York
|
+$30.4M |
| 4 |
N
Nuveen
Charlotte,
North Carolina
|
+$29.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$19.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VVM
Versant Venture Management
San Francisco,
California
|
-$30.1M |
| 2 |
CC
Cannell Capital
Alta,
Wyoming
|
-$20.5M |
| 3 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
-$20.3M |
| 4 |
AI
Atom Investors
Austin,
Texas
|
-$11.1M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$10.6M |
VCYT Hedge Fund Activity: Q2 2019 in Review
195 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2019, worth a combined $1.37B — up 39% from $983M a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new VCYT positions and 14 closed out — a net gain of 49 holders — while 71 added to existing stakes and 50 trimmed.
The largest buyer was Invesco, adding an estimated $59.7M. The largest seller was Versant Venture Management, cutting an estimated $30.1M.
- 195 institutional investors held Veracyte (VCYT) as of Q2 2019, up from 149 in Q1 2019.
- Funds reported $1.37B of Veracyte stock for Q2 2019, up 39% quarter-over-quarter.
- 63 funds opened new Veracyte positions in Q2 2019 and 14 closed out, a net change of +49 holders.
- The largest Veracyte buyer in Q2 2019 was Invesco, an estimated $59.7M added.
- The largest Veracyte seller in Q2 2019 was Versant Venture Management, an estimated $30.1M sold.
Based on aggregated 13F filings for Q2 2019.